NVIDIA Corp. Stock Rises Friday, Outperforms Market

Organon & Co

Change company Symbol lookup

Select an option...

OGN Organon & Co

BBWI Bath & Body Works Inc

OPI Office Properties Income Trust

DHC Diversified Healthcare Trust

GNL-A Global Net Lease Inc

PRS Prudential Financial Inc

LEN Lennar Corp

LEG Leggett & Platt Inc

LDP Cohen & Steers Limited Duration Preferred and Income Fund, Inc

LADR Ladder Capital Corp

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Organon & Co. (Organon) is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands (Organon Products). Organon has a portfolio of contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing, Follistim AQ, and Elonva. The Company’s Biosimilars portfolio spans immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. The Company sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. It operates its manufacturing facilities in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.

NVIDIA Corp. Stock Rises Friday, Outperforms Market

5:14 pm ET May 26, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of NVIDIA Corp. (NVDA) advanced 2.54% to $389.46 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.30% to 4,205.45 and the Dow Jones Industrial Average rising 1.00% to 33,093.34.

This was the stock's second consecutive day of gains.

NVIDIA Corp. closed $5.34 short of its 52-week high ($394.80), which the company reached on May 25th.

Trading volume (71.3 M) eclipsed its 50-day average volume of 45.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 26, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 26, 2023 17:14 ET (21:14 GMT)